Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$6.2 - $9.34 $15,810 - $23,817
2,550 Added 8.58%
32,269 $226,000
Q2 2023

Aug 04, 2023

BUY
$8.76 - $11.92 $8,760 - $11,920
1,000 Added 3.48%
29,719 $274,000
Q1 2023

May 15, 2023

BUY
$10.44 - $12.49 $17,006 - $20,346
1,629 Added 6.01%
28,719 $317,000
Q3 2022

Nov 10, 2022

SELL
$6.25 - $8.94 $6,312 - $9,029
-1,010 Reduced 3.59%
27,090 $223,000
Q1 2022

May 10, 2022

SELL
$5.73 - $7.81 $30,369 - $41,393
-5,300 Reduced 15.87%
28,100 $204,000
Q3 2021

Nov 08, 2021

BUY
$5.52 - $6.97 $5,520 - $6,970
1,000 Added 3.09%
33,400 $213,000
Q2 2021

Aug 11, 2021

BUY
$5.88 - $9.54 $67,032 - $108,755
11,400 Added 54.29%
32,400 $230,000
Q1 2021

May 14, 2021

BUY
$5.12 - $10.6 $107,520 - $222,600
21,000 New
21,000 $176,000

Others Institutions Holding EDAP

About EDAP TMS SA


  • Ticker EDAP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 36,145,300
  • Market Cap $88.6M
  • Description
  • EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. It operates in three segments: High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWav...
More about EDAP
Track This Portfolio

Track Saturna Capital Corp Portfolio

Follow Saturna Capital Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Saturna Capital Corp, based on Form 13F filings with the SEC.

News

Stay updated on Saturna Capital Corp with notifications on news.